Risk factors of HIV vertical transmission in a cohort of women under a PMTCT program at three peri-urban clinics in a resource-poor setting

F Z Gumbo, K Duri, G Q Kandawasvika, N E Kurewa, M P Mapingure, M W Munjoma, S Rusakaniko, M Z Chirenje, B Stray-Pedersen, F Z Gumbo, K Duri, G Q Kandawasvika, N E Kurewa, M P Mapingure, M W Munjoma, S Rusakaniko, M Z Chirenje, B Stray-Pedersen

Abstract

Objective: To identify the risk factors of HIV vertical transmission in pregnant women.

Study design: Observational cohort study. Between 2002 and 2003, 479 HIV-infected pregnant women in a PMTCT (prevention of the mother-to-child transmission) program were followed up with their infants at delivery, until 15 months with infant HIV testing.

Results: Of these 281 infants had a definitive HIV result by 15 months of age, and 31.7% of the infants become HIV infected. In univariate analysis the risk factor identified were presence of vaginal discharge, genital itchiness, genital ulcers, dysuria, abnormal breast and vaginal infections (Trichomonas, Bacteria vaginosis and Candida) in the mother at enrolment. In multivariate analysis vaginal infections risk ratio (RR) 1.72(1.03-2.88) and abnormal breast RR 4.36(2.89-6.58) were predictors of HIV vertical transmission.

Conclusion: There is need to screen for vaginal infections (Trichomonas, Bacteria vaginosis and Candida) and examine pregnant women for mastitis to identify women at risk of HIV vertical transmission for prevention.

Figures

Figure 1
Figure 1
Follow-up of HIV-infected women and their infants.

References

    1. Newell M. Current Issues in the prevention of mother-to-child transmission of HIV-1 infection. Trans R Soc Trop Med Hyg. 2006;100 (1:1–5.
    1. Fawzi W, Msamanga G, Renjifo B, Spieegelman D, Urassa E, Hashemi L, et al. Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women. AIDS. 2001;15 (9:1–9.
    1. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C. Intrapartum and neonatal single-dose nevirapine compared with Zidovudine for prevention of mother to child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795–802.
    1. UNAIDS 2008 , 18/2/2009.
    1. United Nationations General Assembly (UNGASS) Report on HIV and AIDS Zimbabwe country report January 2006-December 2007.
    1. Gill CJ, Sabin LL, Tham J, Hamer DH. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection. Bull World Health Organ. 2004;82 (4:290–298.
    1. Palasanthiran P, Robertson P, Graham G, Hughes C, Ziegler JB.Decay of transplacental human immunodeficiency virus type-1 (HIV-1) antibodies in neonates and infants Annu Conf Australas Soc HIV Med 19946165(abstract).
    1. Taha E, Gray RH.Genital tract infections and perinatal transmission of HIV Ann NY Acad Sci 200091884–98.(abstract).
    1. Bollen LJ, Whitehead SJ, Mock PA, Leelawiwat W, Asavapiriyanont S, Chalermchockchareonkit A, et al. Maternal herpes simplex virus type 2 co-infection increases the risk of perinatal HIV transmission: possibility to further decrease transmission. AIDS. 2008;22 (10:1169–1176.
    1. Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003;362:859–868.
    1. Semba RD. Mastitis and transmission of human immunodeficiency virus through breast milk. Ann NY Acad Sci. 2006;918:156–162.
    1. Embree JE, Njenga S, Datta P, Nagelkerke NJ, Ndinya-Achola JO, Mohammed Z, et al. Risk factors for postnatal mother-child transmission of HIV-1. AIDS. 2000;14 (16:2535–2541.
    1. Ogundele MO, Coulter JB. HIV transmission through breastfeeding: problems and prevention. Ann Trop Paediatri. 2003;23 (2:91–106.
    1. Coovadia HM, Rollins NC, Bland RM, Little K, Coutsoudis A, Bennish ML, et al. Mother to child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet. 2007;369 (957:1107–1116.
    1. Zijenah L, Moulton L, Illif P, Natthoo K, Munjoma M, Mutasa M, et al. Timing of mother to child transmission of HIV -1 and infant mortality in the first 6 months of life in Harare, Zimbabwe. AIDS. 2004;18 (2:273–280.
    1. Bobat R, Coovadia H, Coutsoudis A, Moodley D. Determinants of mother to child transmission of HIV-1 infection in a cohort from Durban, South Africa. Pediatr Infect Dis. 1996;15 (7:604–610.
    1. Magder LS, Mofenson L, Paul ME, Zorrilla CD, Blattner WA, Tuomala RE, et al. Risk factors for in utero and intrapartum transmission of HIV. JAIDS. 2005;38 (1:87–95.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren